Select language:

Russia started producing KoviVac vaccine against coronavirus

 / Главная / Russkiy Mir Foundation / News / Russia started producing KoviVac vaccine against coronavirus

Russia started producing KoviVac vaccine against coronavirus


25.03.2021

Photo credit: jarmoluk / pixabay.com

The Chumakov Scientific Center has launched the production of the KoviVac vaccine against the coronavirus at its own production site, RIA Novosti reports. The Ministry of Science and Higher Education noted that the head of the department Valery Falkov took part in the graduation ceremony.

Thus, another, third, Russian vaccine against coronavirus infection is released into civilian circulation. The Ministry of Education and Science promised that the drug should appear in the Russian regions as soon as possible. The maximum selling price is 4,330 rubles for ten ampoules.

The Chumakov Center highly praised the level of antibodies that appear as a result of vaccination. In the fall, scientists are going to apply to WHO for prequalification. It is planned to produce at least ten million doses by the end of the year.

The 3d Russian vaccine against coronavirus infection was approved in Russia at the end of February. Today, Russia is the only country that has three of its own vaccines against coronavirus. Unlike Sputnik V and EpiVacCorona, CoviVac is a classic whole-virion vaccine, that is, it contains a whole, but killed virus, and not its parts.

Russkiy Mir

News by subject

Publications

Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.